A Pharmacodynamic Biomarker Study Of Vistusertib (Azd2014), An Mtorc1/2 Inhibitor, Given Prior To Radical Prostatectomy (Cancap02).
Simon Pacey,Nimish Shah,Barry R. Davies,Ola Bratt,Anne Warren,Richard D. Baird,Vincent Gnanapragasam, Susan Ingle,Sara Stearn,Andrea Machin,Wendi Qian,Wanfeng Zhao,Elizabeth A. Harrington,Elisabeth Oelmann,Mirela Hategan,Sanjeev Srinivas Kumar,Javier Garcia Corbacho JOURNAL OF CLINICAL ONCOLOGY（2018）
AI 理解论文
溯源树
样例
